The question on how the established msp1/msp2/glurp genotyping method compares with AmpSeq regarding marker diversity, multiplicity of infection (MOI), and trial outcomes, was addressed by applying both typing techniques to the same set of samples. This evidence concerns the gene ATAD1 and infection.